kabutan

StemCell Institute, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 38%, Oct-Dec Ordinary Profit Decreases by 11%

Thu Feb 12, 2026 3:30 pm JST Earnings

7096 StemCell Institute 【J-GAAP】

Earnings Report

StemCell Institute <7096> [TSE Growth] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) dropped 37.9% from the previous period non-consolidated to 228 million yen. Progress toward the full-year plan of 450 million yen was 50.7%, also falling below the five-year average of 86.9%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 3.6 times that of the previous period non-consolidated to 222 million yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 92 million yen, a 10.7% decrease compared to the same period last year. The operating profit margin decreased from 15.0% in the same period last year to 12.1%.

Note: Since of the current fiscal year, the company has transitioned to consolidated financial statements.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 1,884 356 358 254 24.9 85.9 Feb 7, 2024 J-GAAP
Apr - Dec, 2024 2,040 358 367 339 33.2 85.7 Feb 13, 2025 J-GAAP
Apr - Dec, 2025 2,144 218 228 146 14.5 50.7 Feb 12, 2026 J-GAAP
YoY +5.1% -39.1% -37.9% -56.9% -56.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 1,306 160 164 114 11.2 0 May 13, 2025 J-GAAP
Oct - Mar, 2025 Guidance 1,585 320 314 236 23.4 0 Nov 12, 2025 J-GAAP
YoY +21.4% +100.0% +91.5% +107.0% +110.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,481 413 417 310 30.4 0 May 14, 2024 J-GAAP
Mar, 2025 2,679 418 428 385 37.7 25 May 13, 2025 J-GAAP
Mar, 2026 Guidance 3,000 450 450 320 31.8 0 Nov 12, 2025 J-GAAP
YoY +12.0% +7.7% +5.1% -16.9% -15.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 667 100 103 68 6.7 15.0 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 639 60 61 46 4.5 9.4 May 13, 2025 J-GAAP
Apr - Jun, 2025 700 65 67 43 4.2 9.3 Aug 7, 2025 J-GAAP
Jul - Sep, 2025 715 65 69 41 4.1 9.1 Nov 12, 2025 J-GAAP
Oct - Dec, 2025 729 88 92 62 6.2 12.1 Feb 12, 2026 J-GAAP
YoY +9.3% -12.0% -10.7% -8.8% -7.5%

Related Articles